OakChart

iRhythm Holdings Inc

IRTCHealthcare·Medical Devices·USA·Mid·NASD·Nov 11 • 11:37 AM ET

88.86+2.80 (3.25%)
2026-11-11 17:37 CET
Market cap
2,893.17 USD m
Revenue, TTM
854.04 USD m
Net income, TTM
-38.59 USD m
Free cash flow, TTM
7.38 USD m
EPS diluted, TTM
-1.17
P/E
-
Compare

Price

IRTC against its 20, 50 and 200-day averages
2050200beatmiss
80.00100.00120.00140.00160.002.8M5.7MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26IRTCclose 88.8620-day 114.3750-day 112.97200-day 120.1788.8652w low

53.8% under the 52-week high of 192.47 on 26 Nov 2025. 52-week low 82.85 on 10 Nov 2026. Last 15 sessions, 67.0% high to low

Profile

IRTC
52-week range, 5% of the way up
82.85192.47

iRhythm Holdings, Inc. is a digital healthcare company, which engages in the provision of design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.

IndexRUT
Employees2400
IPOOct 20, 2016
Beta1.52
ATR, 14d7.34
Rel volume1.43
Short float9.92%
Insider own2.09%
Inst own104.84%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap2.99B
Enterprise Value3.14B
Income-38.59M
Sales854.04M
Book/sh5.34
Cash/sh16.98
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees2400
IPOOct 20, 2016

Ratios

P/E-
Forward P/E70.01
PEG-
P/S3.50
P/B16.65
P/C5.23
P/FCF404.78
EV/EBITDA45.87
EV/Sales3.68
Quick Ratio3.45
Current Ratio3.57
Debt/Eq4.10
LT Debt/Eq4.00
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.17
EPS next Y1.27
EPS next Q0.15
EPS this Y30.50%
EPS next Y231.38%
EPS next 5Y-
EPS past 3/5Y28.96% 2.49%
Sales past 3/5Y22.05% 23.02%
EPS Y/Y TTM27.87%
Sales Y/Y TTM21.56%
EPS Q/Q-456.73%
Sales Q/Q14.88%
EarningsNov 05 AMC
EPS/Sales Surpr.-5906.45% -0.29%

Ownership

Insider Own2.09%
Insider Trans-8.41%
Inst Own104.84%
Inst Trans-4.27%
ROA-3.70%
ROE-25.81%
ROIC-4.36%
Gross Margin72.26%
Oper. Margin4.87%
Profit Margin-4.52%
SMA20-22.30%
SMA50-21.35%
SMA200-26.06%
Trades-

Technical

Shs Outstand33.19M
Shs Float32.91M
Short Float9.92%
Short Ratio5.08
Short Interest3.27M
52W High192.47 -53.83%
52W Low82.85 7.25%
Volatility11.54% 5.49%
ATR (14)7.34
RSI (14)31.33
Beta1.52
Rel Volume1.43
Avg Volume643.08K
Volume329,677

Performance

Perf Week-33.69%
Perf Month-17.50%
Perf Quarter-27.85%
Perf Half Y-22.50%
Perf YTD-49.92%
Perf Year-49.60%
Perf 3Y22.68%
Perf 5Y-16.49%
Perf 10Y266.73%
Recom1.18
Target Price155.33
Prev Close86.06
Price88.86
Change %3.25%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 06, 2026DowngradeCCitigroupBuy → Neutral$124+39.5%
Oct 16, 2026InitiatedPPiper SandlerOverweight$160+80.1%
Jul 23, 2026InitiatedSStephensOverweight$160+80.1%
Jan 05, 2026UpgradeEEvercore ISIIn-line → Outperform$210+136.3%
Sep 23, 2025InitiatedEEvercore ISIIn-line$185+108.2%
Aug 20, 2025InitiatedBBofA SecuritiesBuy$200+125.1%
May 02, 2025UpgradeWWells FargoEqual Weight → Overweight$130+46.3%
Dec 03, 2024ResumedWWells FargoEqual Weight$86-3.2%
Oct 04, 2024InitiatedGGoldmanNeutral$78-12.2%
Jun 20, 2024UpgradeWWolfe ResearchPeer Perform → Outperform$115+29.4%

Peers

Mkt cap
TickerCompanyMkt cap
BSXBoston Scientific Corp66.33B
PHGKoninklijke Philips NV ADR29.44B
MDTMedtronic Plc129.23B
ABTAbbott Laboratories190.11B
CBLLCeribell Inc1.08B
DXCMDexcom Inc29.72B
BAXBaxter International Inc13.60B
KMTSKestra Medical Technologies Ltd1.84B
HSCSHeartSciences Inc11.78M
BEATHeartBeam Inc23.17M

Insider trading

latest 14 of 45
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Wilson Daniel G.Chief Financial OfficerSep 02 '26Sale121.8377394,17534,887Sep 03 04:01 PM
Blackford Quentin S.President and CEOAug 10 '26Sale124.6526,8593,348,012226,008Aug 11 04:02 PM
Murphy Patrick MichaelCBO and CLOAug 10 '26Sale124.657,093884,15669,699Aug 11 04:02 PM
Patterson ChadCHIEF COMM & PRODUCT OFFICERAug 10 '26Sale124.657,093884,17062,125Aug 11 04:01 PM
Shrishrimal SumiEVP, Chief Risk OfficerAug 10 '26Sale124.655,372669,64144,621Aug 11 04:01 PM
Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECHAug 10 '26Sale124.657,093884,15160,116Aug 11 04:00 PM
Smith MervinEVP Strategic Business OpsAug 03 '26Sale122.1261775,34922,410Aug 04 04:02 PM
Rodda JulianneEVP, CHIEF PEOPLE OFFICERAug 03 '26Sale122.122,112257,91918,201Aug 04 04:01 PM
Patterson ChadCHIEF COMM & PRODUCT OFFICERAug 03 '26Sale122.122,712331,19255,629Aug 04 04:01 PM
Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECHJul 02 '26Sale124.711,423177,46253,620Jul 06 04:03 PM
Freeman Sean ClintonEVP, Strategy & Corp DevtJul 02 '26Sale124.71918114,48413,641Jul 06 04:03 PM
Shrishrimal SumiEVP, Chief Risk OfficerJun 02 '26Sale108.191,716185,65240,287Jun 03 04:16 PM
Rosenbaum Marc WadeChief Accounting OfficerJun 02 '26Sale108.1972978,87016,155Jun 03 04:15 PM
TALWALKAR ABHIJIT YDirectorMay 11 '26Buy10.715,31256,89225,611May 12 05:12 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
IHIiShares U.S. Medical Devices ETFAUM: 4.07B
VHTVanguard Health Care ETFAUM: 21.51B

News

latest 14 of 206
  • iRhythm Holdings to Participate in Upcoming Investor Conferences (GlobeNewswire) -30.70%
  • IRhythm's Record Margins Mask A Growth Slowdown As Acquired VitalConnect Revenue Carries The Guidance Raise (Earnings Whispers)
  • iRhythm Holdings Announces Third Quarter 2026 Financial Results (GlobeNewswire)
  • IRhythm's Q3 Report Tests Whether Its 20% Growth Streak Can Survive A Cautious Street (Earnings Whispers)
  • iRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026 (GlobeNewswire)
  • Loading…
  • Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
  • iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care (GlobeNewswire)
  • iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026 (GlobeNewswire)
  • Here's how to position your portfolio for the next AI wave, according to Morgan Stanley (MarketWatch)
  • iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference (GlobeNewswire)
  • Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire) -7.53%
  • IRhythm grows heart monitoring leadership with $288M VitalConnect buy (MedTech Dive)
  • The Doctor Will See You Now…Everywhere (Barrons.com)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-05-0.9000.016-0.900221.59222.2311
2026Q22026-08-06-0.010-0.040-0.012224.17219.310
2026Q12026-04-30-0.430-0.659-0.429199.39194.119
2025Q42026-02-190.1700.0110.167208.89201.911
2025Q32025-10-30-0.160-0.324-0.162192.88184.7712
2025Q22025-07-31-0.440-0.484-0.444186.69173.989
2025Q12025-05-01-0.970-0.961-0.972158.68153.389
2024Q42025-02-20-0.040-0.331-0.043164.33158.110
2024Q32024-10-30-1.480-0.795-1.477147.5414710
2024Q22024-08-01-0.650-0.893-0.646148.05146.1511
2024Q12024-05-02-1.470-0.973-1.472131.93128.4111
2023Q42024-02-22-1.260-0.579-1.261132.51130.210
2023Q32023-11-02-0.890-0.637-0.886124.6122.6110
2023Q22023-08-03-0.610-0.762-0.606124.13120.2910
2023Q12023-05-04-1.290-0.899-1.291111.44107.059
2022Q42023-02-23-0.670-0.622-0.670112.62110.2610

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-2.160-2.031-2.160214.55213.89
2020FY-1.580-1.532-1.579265.17263.12
2021FY-3.460-3.525-3.456322.83319.68
2022FY-3.880-3.462-3.883410.92408.46
2023FY-4.040-3.119-4.042492.68490.37
2024FY-3.630-3.669-3.632591.84585.34
2025FY-1.390-1.502-1.390747.14739.92
2026FY--0.966--892.83
2027FY-1.269--1,070
2028FY-2.238--1,227
2029FY-3.315--1,414
2030FY-5.460--1,668

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0916123247.56242.6250.61
2026Q4S2026-11-0616113247.15241.25250.61
2026Q4S2026-11-051630244.61238267.5
2026Q4S2026-10-211630244.61238267.5
2026Q4S2026-10-151631244.61238267.5
2026Q4S2026-10-131531244.9238267.5
2026Q4S2026-10-091521243.79238267.5
2026Q4S2026-10-051521243.79238267.5
2026Q4S2026-10-021521242.56238267.5
2026Q4S2026-09-241511240.87238243.07
2026Q4S2026-08-191511240.88238243.07
2026Q4S2026-08-171411240.75238243.07
2026Q4S2026-08-091411240.75238243.07
2026Q4S2026-08-071511240.79238243.07

Estimate history

EPS, annual-1.3-2.109-2.16-1.579-3.456-3.883-4.042-3.632-1.392-1.1747
Period201720182019202020212022202320242025TTM
EPS, quarterly-1.477-0.043-0.972-0.444-0.1620.167-0.429-0.012-0.902
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual98.509147.277214.552265.166322.825410.921492.681591.839747.138854.04
Period201720182019202020212022202320242025TTM
Sales, quarterly147.538164.325158.677186.687192.884208.89199.39224.172221.592
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual23.37724.36826.68329.01929.49430.19330.95431.39232.29733.185
Period201720182019202020212022202320242025MRQ
Shares, quarterly31.28731.39231.91532.10532.20532.29732.85432.94433.185
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue854.04747.14591.84492.68410.92322.82265.17214.55147.28
Cost of Goods Sold Incl. D&A236.94219.89184.31160.88129.29109.2670.2852.4838.80
Gross Profit617.11527.25407.53331.81281.63213.57194.89162.07108.48
Selling, General and Administrative Excl. Other575.51564.06490.02445.89368.81313.51238.56216.82154.17
Research and Development82.8584.6171.4660.2446.6138.6741.3337.3020.86
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income41.59-36.81-82.49-114.08-87.18-99.94-43.67-54.76-45.69
Interest Expense13.2013.1512.823.654.141.171.521.643.12
Unusual Expense85.6714.8938.7011.0826.610.000.000.003.03
Net Income Before Taxes-37.64-43.60-112.72-122.66-115.89-100.99-43.60-54.50-50.33
Income Taxes0.950.950.560.750.270.370.230.070.04
Consolidated Net Income-38.59-44.55-113.29-123.41-116.16-101.36-43.83-54.57-50.38
Net Income From Continuing Operations-38.59-44.55-113.29-123.41-116.16-101.36-43.83-54.57-50.38
Net Income-38.59-44.55-113.29-123.41-116.16-101.36-43.83-54.57-50.38
EPS (Recurring)0.65-1.07-2.76-3.79-3.26-3.46-1.58-2.16-2.02
EPS (Basic, Before Extraordinaries)-1.17-1.39-3.63-4.04-3.88-3.46-1.58-2.16-2.11
EPS (Diluted)-1.17-1.39-3.63-4.04-3.88-3.46-1.58-2.16-2.11
EBITDA68.50-10.33-56.72-91.94-67.57-83.35-30.74-42.36-43.42
Non-Operating Income (Expense)19.6421.2521.296.162.040.121.591.901.50
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense68.9769.7460.0260.9945.6139.8030.3119.1612.90
Price To Sales Ratio4.407.604.756.636.8210.6924.838.0211.27
Gross Margin72.2670.5768.8667.3568.5466.1673.5075.5473.66
Operating Margin4.87-4.93-13.94-23.16-21.21-30.96-16.47-25.52-31.02
Net Margin-4.52-5.96-19.14-25.05-28.27-31.40-16.53-25.43-34.21
Shares Outstanding33.1932.3031.3930.9530.1929.4929.0226.6824.37
Market Capitalization2,893.172,893.172,822.143,280.862,820.493,463.136,848.581,812.831,680.17

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue221.59224.17199.39208.89192.88186.69158.68164.32
Cost of Goods Sold Incl. D&A57.1060.9758.0460.8455.7653.8349.4649.26
Gross Profit164.49163.21141.35148.06137.12132.86109.22115.07
Selling, General and Administrative Excl. Other138.29144.73153.21139.29141.12147.39141.48118.85
Research and Development20.6019.8421.3621.0521.0321.0121.5219.08
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income26.2018.48-11.858.77-4.00-14.53-32.26-3.78
Interest Expense3.303.293.293.323.283.283.273.32
Unusual Expense57.9220.202.884.663.536.331.14-0.54
Net Income Before Taxes-29.85-0.38-13.436.03-5.19-14.40-30.04-1.18
Income Taxes0.000.000.500.450.02-0.180.670.15
Consolidated Net Income-29.85-0.38-13.935.58-5.21-14.22-30.70-1.33
Net Income From Continuing Operations-29.85-0.38-13.935.58-5.21-14.22-30.70-1.33
Net Income-29.85-0.38-13.935.58-5.21-14.22-30.70-1.33
EPS (Recurring)0.320.42-0.370.27-0.09-0.31-0.95-0.05
EPS (Basic, Before Extraordinaries)-0.90-0.01-0.430.17-0.16-0.44-0.97-0.04
EPS (Diluted)-0.90-0.01-0.430.17-0.16-0.44-0.97-0.04
EBITDA33.0925.23-5.3115.492.62-8.00-25.662.82
Non-Operating Income (Expense)5.174.634.595.245.639.746.645.38
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense19.4915.8316.9816.6716.5918.0318.4412.65
Price To Sales Ratio4.404.744.877.927.887.495.354.78
Gross Margin74.2372.8070.8970.8871.0971.1768.8370.02
Operating Margin11.828.24-5.954.20-2.07-7.78-20.33-2.30
Net Margin-13.47-0.17-6.992.67-2.70-7.62-19.35-0.81
Shares Outstanding33.1932.9432.8532.3032.2032.1031.9131.39
Market Capitalization2,893.173,908.983,814.035,716.965,525.664,915.223,287.962,822.14

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments583.76535.55133.76213.14239.13335.22140.5578.34102.36
Short Term Receivables75.7179.9461.4849.9246.4329.9323.8719.7912.95
Inventories21.6314.0413.9715.1510.275.314.042.061.68
Other Current Assets21.6616.2921.5910.559.697.364.344.102.58
Total Current Assets702.76645.82230.81288.77305.52377.82172.79104.30119.58
Net Property, Plant & Equipment193.43172.66153.43136.34140.53118.96116.599.166.22
Total Investments and Advances78.2770.263.000.000.000.008.030.002.99
Intangible Assets0.860.860.860.860.860.860.860.860.86
Other Assets44.7241.8545.0422.2516.0514.097.943.213.46
Total Assets1,020.04931.45433.14448.22462.97511.74306.21117.52133.12
Short Term Debt Incl. Current Port. of LT Debt16.6915.8715.1613.0322.8119.849.860.001.49
Accounts Payable2.267.225.547.5210.514.378.242.282.40
Income Tax Payable1.82-2.882.39-----
Other Current Liabilities131.1387.8383.7966.1654.5341.4633.9728.0517.04
Total Current Liabilities151.89110.92107.3789.1087.8565.6752.0730.3320.92
Long Term Debt714.50721.04114.67118.0194.90102.63118.7434.9032.49
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities0.918.581.011.310.701.830.000.150.16
Total Liabilities867.30840.54223.05208.41183.45170.13170.8065.3953.57
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity152.7590.91210.10239.81279.51341.61135.4152.1479.55
Total Shareholders Equity152.7590.91210.10239.81279.51341.61135.4152.1479.55
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity152.7590.91210.10239.81279.51341.61135.4152.1479.55
Total Liabilities & Stockholders Equity1,020.04931.45433.14448.22462.97511.74306.21117.52133.12
Book Value Per Share4.732.906.797.949.4811.775.072.143.40
Tangible Book Value Per Share4.702.876.767.919.4511.745.042.103.37
Full-Time Employees2,4002,0002,0001,7931,7001,157997748575
Price to Book Ratio16.1339.3114.9211.7812.4220.1513.4231.1115.08
Return on Assets-4.57-16.60-28.00-25.50-20.80-10.72-25.62-40.20-21.69
Return on Equity-36.57-75.27-54.86-44.73-32.64-18.38-57.49-76.51-34.19
Return on Invested Capital-5.14-13.95-38.00-32.46-27.07-9.87-21.47-57.88-26.26
Quick Ratio4.485.702.023.073.365.673.243.375.64
Current Ratio4.635.822.153.243.485.753.323.445.72

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-38.59-44.55-113.29-123.41-116.16-101.36-43.83-54.57-50.38
Depreciation26.9126.4825.7822.1419.6116.5912.9312.402.27
Other Funds (Non Cash)185.33190.63190.02153.21139.0493.2473.3850.0432.04
Funds from Operations173.65172.56102.5151.9542.508.4742.487.87-16.07
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-118.09-91.70-99.12-102.05-65.51-46.23-56.23-29.73-13.03
Cash from Operating Activities55.5680.863.39-50.10-23.01-37.75-13.76-21.86-29.09
Capital Expenditures-48.18-46.34-33.94-40.42-29.83-28.07-13.55-20.46-5.18
Net Assets From Acquisitions-10.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments144.16-230.71-74.0439.22-22.60133.33-118.84-68.8239.32
Purchase of Investments-437.81-468.41-175.24-167.28-188.57-122.18-277.51-165.91-93.13
Sale Or Maturity of Investments581.96237.70101.20206.50165.97255.51158.6797.10132.46
Other Uses0.000.00-15.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities85.98-277.06-122.98-1.21-52.43105.26-132.39-89.2734.14
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock7.5912.61644.728.8213.188.94226.27116.869.32
Repurchase of Common Pref Stock0.000.00-25.000.000.000.000.000.000.00
Sale of Common Pref Stock7.5912.61669.728.8213.188.94226.27116.869.32
Proceedsfrom Stock Options7.5912.61669.728.8213.188.94226.27116.869.32
Issuance or Reduction of Debt, Net-0.000.00-60.940.0013.53-11.67-1.940.003.38
Change in Long Term Debt-0.000.00-60.940.0013.53-11.67-1.940.003.38
Issuance of Long Term Debt0.000.0055.480.0034.920.000.000.0034.88
Reduction of Long Term Debt-0.000.00-116.410.00-21.39-11.67-1.940.00-31.50
Net Financing Active Other Cash Flow0.000.00-72.410.000.00-25.85-10.01-5.29-6.39
Other Financing Activities Uses0.000.00-72.410.000.00-25.85-10.01-5.29-6.39
Cash from Financing Activities7.5912.61511.388.8226.72-28.58214.32111.586.30
Exchange Rate Effect-0.010.00-0.01-0.17-----
Net Change in Cash149.11-183.59391.78-42.66-48.7338.9368.170.4411.35
Free Cash Flow7.3834.52-30.55-90.53-52.84-65.82-27.31-42.32-34.27
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow509.69164.50-------
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments570.72591.27549.62583.76565.21545.54
Short Term Receivables119.6584.2780.8675.7176.1682.15
Inventories23.2222.5123.8021.6319.5618.40
Other Current Assets16.6257.8926.2721.6619.1117.82
Total Current Assets730.21755.95680.56702.76680.03663.92
Net Property, Plant & Equipment214.61204.10197.03193.43192.62184.45
Total Investments and Advances82.8782.0481.2278.2776.4573.25
Intangible Assets0.860.860.860.860.860.86
Other Assets62.8950.4746.7044.7245.2541.54
Total Assets1,091.441,093.431,006.371,020.04995.21964.03
Short Term Debt Incl. Current Port. of LT Debt17.0416.9116.7916.6916.5316.36
Accounts Payable15.3917.418.562.268.2812.78
Income Tax Payable---1.82--
Other Current Liabilities172.30161.78106.40131.13122.11103.08
Total Current Liabilities204.73196.10131.75151.89146.91132.21
Long Term Debt708.70710.44712.50714.50716.49718.38
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.910.910.910.919.939.78
Total Liabilities914.34907.44845.15867.30873.32860.37
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity177.11185.98161.21152.75121.89103.66
Total Shareholders Equity177.11185.98161.21152.75121.89103.66
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity177.11185.98161.21152.75121.89103.66
Total Liabilities & Stockholders Equity1,091.441,093.431,006.371,020.04995.21964.03
Book Value Per Share5.345.654.914.733.783.23
Tangible Book Value Per Share5.315.624.884.703.763.20
Full-Time Employees---2,400--
Price to Book Ratio16.1324.2424.9546.8853.2756.70
Return on Assets-3.70-1.36-2.88-4.57-5.40-9.82
Return on Equity-25.81-9.63-22.42-36.57-53.15-91.13
Return on Invested Capital-3.37-0.04-1.590.64-0.62-1.73
Quick Ratio3.453.744.984.484.504.88
Current Ratio3.573.855.174.634.635.02

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-29.85-0.38-13.935.58-5.21-14.22
Depreciation6.886.756.546.736.626.53
Other Funds (Non Cash)46.4848.9448.6041.3046.5250.31
Funds from Operations23.5155.3141.2253.6147.9242.62
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-19.07-4.24-67.39-27.39-13.04-14.96
Cash from Operating Activities4.4451.08-26.1726.2134.8827.66
Capital Expenditures-15.98-13.56-6.91-11.72-14.83-10.37
Net Assets From Acquisitions-10.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments179.18-35.0737.12-37.08-74.37-90.55
Purchase of Investments-55.78-160.92-95.53-125.58-173.37-135.15
Sale Or Maturity of Investments234.96125.85132.6588.5099.0044.60
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities153.20-48.6430.21-48.80-89.20-100.92
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.404.080.152.960.827.09
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.404.080.152.960.827.09
Proceedsfrom Stock Options0.404.080.152.960.827.09
Issuance or Reduction of Debt, Net0.00-0.000.000.000.000.00
Change in Long Term Debt0.00-0.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.00-0.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.404.080.152.960.827.09
Exchange Rate Effect-0.000.01-0.060.03-0.00-0.01
Net Change in Cash158.046.534.13-19.59-53.50-66.17
Free Cash Flow-11.5437.52-33.0814.4920.0517.29
Price to Free Cash Flow509.69100.39204.58171.33170.66176.65

Revenue breakdown

Centers For Medicare And Medicaid2024: 142.39M 2025: 179.35M
Commercial Payors2024: 311.61M 2025: 392.23M
Healthcare Institutions2024: 95.12M 2025: 125.61M
Non-contracted Third-party Payors2024: 42.73M 2025: 49.94M
United States2024: 591.84M 2025: 747.14M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3010.12%3.3M32.3M562.97K
2026-10-159.59%3.1M32.3M562.41K
2026-09-309.40%3.0M32.3M585.54K
2026-09-159.47%3.1M32.3M615.83K
2026-08-318.64%2.8M32.3M606.92K
2026-08-148.67%2.8M32.3M614.36K
2026-07-319.93%3.2M32.4M574.98K
2026-07-1510.63%3.4M32.3M566.29K
2026-06-3010.03%3.2M32.3M530.30K
2026-06-159.09%2.9M32.3M510.99K
2026-05-299.78%3.2M32.3M547.19K
2026-05-159.56%3.1M32.4M582.58K
2026-04-308.86%2.9M32.2M591.60K
2026-04-159.38%3.0M32.2M624.06K
2026-03-319.26%2.9M31.8M696.83K
2026-03-139.09%2.9M31.8M663.15K
2026-02-2710.67%3.4M31.8M602.91K
2026-02-1310.70%3.4M31.8M574.99K
2026-01-308.93%2.8M31.7M563.51K
2026-01-158.68%2.8M31.7M517.86K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call55.0032.6035.100.002.6880.000.000.924-0.2710.020
call60.0027.6030.2026.502.1721.000.000.912-0.2620.022
call65.0022.6025.200.001.9670.000.000.896-0.2470.025
call70.0017.7020.3061.001.6621.000.000.875-0.2300.029
call75.0012.9015.400.001.2460.000.000.848-0.2120.033
call80.008.4010.5012.000.9511.000.000.803-0.1850.039
call85.004.006.307.500.7742.000.000.661-0.2190.051
call90.000.803.501.000.73731.000.000.477-0.2470.055
call95.000.051.251.300.63643.000.000.251-0.1600.044
call1000.001.150.010.83864.003.000.191-0.1770.038
call1050.001.350.001.0410.000.000.162-0.1970.034
call1100.002.200.151.20818.000.000.145-0.2130.032
call1150.000.100.100.8272010.000.024-0.0360.008
call1200.002.150.100.93220.000.000.022-0.0380.007
call1250.000.100.071.0552860.000.019-0.0360.007
call1300.002.156.701.1343550.000.019-0.0400.006
call1350.002.157.681.22233.000.000.017-0.0410.006
call1400.002.150.051.3091220.000.016-0.0410.006
call1450.002.151.601.39110.000.000.016-0.0420.005
call1500.002.152.201.4711050.000.015-0.0430.005
call1550.002.150.511.54628.000.000.014-0.0430.005
call1600.002.153.321.6194.000.000.014-0.0440.005
call1650.000.804.601.6811.000.000.013-0.0410.005
call1700.000.501.421.7458.000.000.013-0.0410.005
call1750.001.001.851.8071.000.000.012-0.0420.005
call1800.002.151.701.88445.000.000.012-0.0460.004
call1850.002.150.001.9440.000.000.012-0.0460.004
call1900.002.150.002.0030.000.000.012-0.0460.004
put55.000.002.150.202.45220.000.00-0.075-0.2670.020
put60.000.002.201.702.0591.000.00-0.089-0.2530.022
put65.000.002.252.351.7381.000.00-0.104-0.2400.025
put70.000.002.300.441.4222.000.00-0.125-0.2230.029
put75.000.002.450.001.1200.000.00-0.153-0.2020.033
put80.000.301.350.930.81415.004.00-0.202-0.1750.039
put85.001.202.502.000.72783.0010.00-0.351-0.2110.051
put90.002.805.504.680.8288.005.00-0.535-0.2360.055
put95.006.208.108.930.65836.000.00-0.752-0.1480.044
put10010.6012.4013.500.8051390.00-0.807-0.1640.038
put10515.0017.7017.341.0864.000.00-0.836-0.1840.035
put11019.9022.8022.291.2970.000.00-0.854-0.2000.032
put11524.9027.802.001.3740.000.00-0.976-0.0240.008
put12029.9033.0025.501.5360.000.00-0.978-0.0240.007
put12534.9038.0015.701.6950.000.00-0.980-0.0250.007
put13039.9042.8020.401.7490.000.00-0.981-0.0250.006
put13544.9047.8031.001.8710.000.00-0.983-0.0260.006
put14049.9053.000.002.0700.000.00-0.984-0.0260.006
put14554.9058.000.002.1820.000.00-0.984-0.0260.005
put15059.9063.000.002.2890.000.00-0.985-0.0260.005
put15564.9068.000.002.3910.000.00-0.986-0.0260.005
put16069.9072.800.002.4530.000.00-0.986-0.0260.005
put16574.9077.600.002.3880.000.00-0.987-0.0260.005
put17079.9082.800.002.5790.000.00-0.987-0.0260.005
put17584.9087.600.002.5590.000.00-0.988-0.0260.004
put18090.0092.600.002.6390.000.00-0.988-0.0260.004
put18595.0097.600.003.0630.000.00-0.988-0.0250.004
put190100102.60.002.7930.000.00-0.988-0.0250.004

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-10-13SCHEDULE 13G/ASEC
2026-10-058-KCurrent report2026-10-05SEC
2026-09-228-KCurrent report2026-09-22SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-138-KCurrent report2026-08-11SEC
2026-08-13SCHEDULE 13GSEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-07SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-07SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-07SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-07SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-07SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-05SEC
2026-08-068-KCurrent report2026-07-31SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-07-064Statement of changes in beneficial ownership of securities2026-07-02SEC
2026-07-064Statement of changes in beneficial ownership of securities2026-07-02SEC
2026-06-158-KCurrent report2026-06-10SEC
2026-06-058-KCurrent report2026-06-03SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-014Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-014Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-014Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-06-014Statement of changes in beneficial ownership of securities2026-05-29SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090094.17K1
2026-08007.33M8
2026-0700291.95K2
2026-0600264.52K2
2026-0556.89K1748.92K2
2026-040000
2026-03004.80M9
2026-020010.44M11
2026-010000
2025-1200509.76K2
2025-11003.50M2

Institutional holders

Manager% owned
TUDOR INVESTMENT CORP ET AL66.19%
STATE OF WISCONSIN INVESTMENT BOARD12.31%
BlackRock, Inc.9.09%
RTW INVESTMENTS, LP6.64%
VANGUARD PORTFOLIO MANAGEMENT LLC5.82%
Artisan Partners Limited Partnership5.05%
VANGUARD CAPITAL MANAGEMENT LLC4.45%
MILLENNIUM MANAGEMENT LLC4.28%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC2.87%
EVENTIDE ASSET MANAGEMENT, LLC2.68%

Funds

Fund% owned
NYLIM VP MacKay Convertible Portfolio46.05%
NYLIM MacKay Convertible Fund43.77%
iShares Convertible Bond ETF42.37%
Columbia Convertible Securities Fund33.01%
State Street(R) SPDR(R) Bloomberg Convertible Securities ETF30.13%
Fidelity Convertible Securities Fund13.39%
Advent Convertible & Income Fund8.84%
Invesco Convertible Securities Fund7.53%
Fidelity Strategic Dividend and Income Fund5.04%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.12%

OakChart. IRTC. Cached 15 minutes.